The DEA (the U.S. drug enforcement agency) will publicly announce at least three separate enforcement actions (raids, arrests, or clinic closures) against ketamine clinics in three different U.S. states before October 2026. Ketamine clinics operate in a legal gray zone—they prescribe ketamine (a legal but controlled anesthetic) for depression and pain, often via telemedicine. The DEA will likely target these clinics because the current political environment favors aggressive drug enforcement.
Ketamine clinics operating via telemedicine prescriptions represent the most legally accessible enforcement target: ketamine is Schedule III, clinics are operating in regulatory gray zones, and DEA has existing jurisdictional authority without needing Schedule I case construction. The current law-enforcement-friendly political climate provides cover for visible action. Three separate states is a specific, falsifiable threshold distinguishing a pattern from isolated incidents. Resolves via DEA press releases, DOJ announcements, or credible news reporting of raids/license actions.